ContraFect (CFRX) Prices 11.797M Share & Warrants Offering at $4.90/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
After-Hours Movers Stock 05/21: (RAMP) (PANW) (ELF) Higher; (GERN) (CFRX) (DVAX) Lower (more...)
May 21, 2020 6:00 PM EDTToday's After-Hours Stock Movers:
Geron Corporation (Nasdaq: GERN) 17.9% LOWER; announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of its common stock in an underwritten public offering. All of the securities in the proposed offering are to be sold by Geron. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
ContraFect... More
ContraFect (CFRX) Announces Proposed Public Offering of Common Stock and Warrants
May 21, 2020 4:12 PM EDTContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the treatment of life-threatening infectious diseases, today announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase additional shares... More
